Success of COVID-19 Antibody Assay Development
We are developing two assays to support the COVID-19 diagnostic effort. AgPlus has been working on an antigen assay and antibody assay.
Development and Manufacture of Our Diagnostic Reader with Key Partner STI
Key Partner STI supports Ground-breaking Antibiotic Resistance Project
In Vitro Diagnostic Regulations. The Impact of Implementation on SME’s
White Paper : The impact of implementing the new In Vitro Diagnostic Regulations on SMEs
The Simultaneous Detection of Two Analytes on the Agilis System Using Silver and Gold Nanoparticles
Ag Plus release new white paper – This piece of work has shown that dual detection system for two different analytes can be accomplished on the AgPlus system using differing AuNP and AgNP simultaneously.
Top five problems of developing a near patient diagnostic assay.
We discuss the problems of developing a near patient diagnostic assay…
AG Plus release White Paper – using a Point of Care Assay to detect Human Neutrophil Lipocalin
Every 4 minutes worldwide someone dies from infection caused by bacteria that are resistant to antibiotics. Using a Point of Care Assay to detect Human Neutrophil Lipocalin would improve patient outcome.
AG Plus release Challenges to Point-of-Care Testing White Paper
Point-of-care tests (POCT) offer rapid diagnostic and/or predictive results in real-time thereby facilitating clinical decision making. We discuss how our technology overcomes implementation challenges.
